Comments
Loading...

Aptevo Therapeutics (APVO) Stock Price, Quote, News & History

APVONASDAQ
Logo brought to you by Benzinga Data
$9.45
0.424.60%
At close: Jan 16, 4:00 PM EST
$9.02
-0.43-4.50%
After Hours: Jan 16, 9:29 AM EST
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open
$9.01
Close
$9.45
Volume / Avg.
77.58K / 173.18K
Day Range
$8.82 - $9.60
52 Wk Range
7.66 - 1.81K
Market Cap
$9.00M
P/E Ratio
0.00
Dividend Yield
-
Exchange
NASDAQ
RSI
33
Short Interest
14.03%
Days to Cover
1.03
60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-26.12M
Investing Cash Flow (TTM)
0
Financing Cash Flow (TTM)
39.42M
Free Cash Flow (TTM)
-26.12M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
13.31M

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$7.65M
PE Ratio (TTM)
0.00
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.54
Earnings Yield % (TTM)
82140.80%
Earnings Yield % (FWD)
-304.92%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$17.43

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$21.06M
Debt to Equity
0.23
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$9.01
Close
$9.45
Volume / Avg.
77.58K / 173.18K
Day Range
$8.82 - $9.60
52 Wk Range
7.66 - 1.81K
Market Cap
$9.00M
P/E Ratio
0.00
Dividend Yield
-
Exchange
NASDAQ
RSI
33
Short Interest
14.03%
Days to Cover
1.03

About

Sector
Health Care
Industry
Biotechnology
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which target...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
APVO
ERNA

FAQ

Q

How do I buy Aptevo Therapeutics (APVO) stock?

A

You can purchase shares of Aptevo Therapeutics (NASDAQ:APVO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aptevo Therapeutics (APVO) competitors?

Q

What is the forecast, or price target, for Aptevo Therapeutics (APVO) stock?

A

Aptevo Therapeutics has a consensus price target of $8.00.

Q

What is the current price for Aptevo Therapeutics (APVO)?

A

The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $9.02 last updated January 16, 2026 at 9:29 AM EST.

Q

Does Aptevo Therapeutics (APVO) pay a dividend?

A

There are no upcoming dividends for Aptevo Therapeutics.

Q

When is Aptevo Therapeutics (NASDAQ:APVO) reporting earnings?

A

Aptevo Therapeutics does not have any upcoming earnings scheduled.

Q

Is Aptevo Therapeutics (APVO) going to split?

A

There is no upcoming split for Aptevo Therapeutics.

Q

What sector and industry does Aptevo Therapeutics (APVO) operate in?

A

Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.